This week on dvm360: New podcast episodes, plus exciting product news

Verdinexor tablets are now available for dogs with lymphoma after receiving full FDA approval earlier this year, offering an at-home treatment option that is given twice weekly and showed a longer time to disease progression than control in a field study.

Preclinical testing at The Ohio State University found Telomir-Zn inhibited growth of canine and human osteosarcoma cell lines, prompting the company to explore a possible in-vivo study in dogs with naturally occurring tumors.

Caroline Cox, LSW, MSW, and Erika Krick, VMD, DACVIM (Oncology), discuss the role of veterinary social workers in supporting clients, communicating with veterinary teams, and helping practices address the human side of veterinary care in this Q&A from an interview at the 2026 Fetch National Harbor Veterinary Conference.

In a session at the 2026 Fetch National Harbor Veterinary Conference, Nathanael Oster, VMD, MBA, walked attendees through the biology, diagnosis, and treatment of the flea tapeworm in dogs and cats, including why cats are affected more often than dogs.

In a slideshow drawn from an on-site dvm360 interview at the 2026 Fetch National Harbor Veterinary Conference, a veterinary oncologist and a veterinary social worker walk through how the role supports owners and staff across a pet's cancer diagnosis, treatment, and end-of-life care.

A plethora of continuing-education sessions run across 3 days, September 17–19, at the Gaylord National Resort in National Harbor, MD. Here are the ones to circle first, sorted by practice area, plus a handful that are easy to scroll past and worth catching.

Christopher Lee, DVM, MPH, DACVPM, DACVM (Parasitology), discusses the clinical significance of Toxoplasma gondii, when veterinary professionals should consider testing, and how to communicate the risks of exposure to clients.

The update covers diagnosis, slowing progression, managing complications, and supporting caregivers of cats with chronic kidney disease.